A systematic review of physicians' survival predictions in terminally ill cancer patients
- PMID: 12881260
- PMCID: PMC166124
- DOI: 10.1136/bmj.327.7408.195
A systematic review of physicians' survival predictions in terminally ill cancer patients
Abstract
Objective: To systematically review the accuracy of physicians' clinical predictions of survival in terminally ill cancer patients.
Data sources: Cochrane Library, Medline (1996-2000), Embase, Current Contents, and Cancerlit databases as well as hand searching.
Study selection: Studies were included if a physician's temporal clinical prediction of survival (CPS) and the actual survival (AS) for terminally ill cancer patients were available for statistical analysis. Study quality was assessed by using a critical appraisal tool produced by the local health authority.
Data synthesis: Raw data were pooled and analysed with regression and other multivariate techniques.
Results: 17 published studies were identified; 12 met the inclusion criteria, and 8 were evaluable, providing 1563 individual prediction-survival dyads. CPS was generally overoptimistic (median CPS 42 days, median AS 29 days); it was correct to within one week in 25% of cases and overestimated survival by at least four weeks in 27%. The longer the CPS the greater the variability in AS. Although agreement between CPS and AS was poor (weighted kappa 0.36), the two were highly significantly associated after log transformation (Spearman rank correlation 0.60, P < 0.001). Consideration of performance status, symptoms, and use of steroids improved the accuracy of the CPS, although the additional value was small. Heterogeneity of the studies' results precluded a comprehensive meta-analysis.
Conclusions: Although clinicians consistently overestimate survival, their predictions are highly correlated with actual survival; the predictions have discriminatory ability even if they are miscalibrated. Clinicians caring for patients with terminal cancer need to be aware of their tendency to overestimate survival, as it may affect patients' prospects for achieving a good death. Accurate prognostication models incorporating clinical prediction of survival are needed.
Figures



Comment in
-
Survival predictions may hasten death.BMJ. 2003 Nov 1;327(7422):1048-9. doi: 10.1136/bmj.327.7422.1048-d. BMJ. 2003. PMID: 14593055 Free PMC article. No abstract available.
Similar articles
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090. Health Technol Assess. 2006. PMID: 16545208
Cited by
-
Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.Head Neck. 2021 Aug;43(8):2445-2456. doi: 10.1002/hed.26716. Epub 2021 May 7. Head Neck. 2021. PMID: 33960553 Free PMC article.
-
Negotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians - A qualitative interview study.Front Oncol. 2022 Sep 23;12:870431. doi: 10.3389/fonc.2022.870431. eCollection 2022. Front Oncol. 2022. PMID: 36212451 Free PMC article.
-
Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis.Onco Targets Ther. 2016 Mar 22;9:1679-88. doi: 10.2147/OTT.S95744. eCollection 2016. Onco Targets Ther. 2016. PMID: 27042122 Free PMC article.
-
A Literature Review on Care at the End-of-Life in the Emergency Department.Emerg Med Int. 2012;2012:486516. doi: 10.1155/2012/486516. Epub 2012 Mar 6. Emerg Med Int. 2012. PMID: 22500239 Free PMC article.
-
Survival predictions may hasten death.BMJ. 2003 Nov 1;327(7422):1048-9. doi: 10.1136/bmj.327.7422.1048-d. BMJ. 2003. PMID: 14593055 Free PMC article. No abstract available.
References
-
- Christakis NA. The ellipsis of prognosis in modern medical thought. Soc Sci Med 1997;44: 301-15. - PubMed
-
- Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians and other care providers. JAMA 2000;284: 2476-82. - PubMed
-
- Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Alzamor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 2000;14: 363-74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous